(AZE) Azelis - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974400328
AZE: Specialty Chemicals, Food Ingredients
Azelis Group NV is a leading global distributor of specialty chemicals and food ingredients, operating across multiple end markets. The company serves industries such as life sciences (personal care, home care, pharmaceuticals, healthcare, food and nutrition, animal nutrition, flavors and fragrances, and agricultural environmental solutions) and industrial chemicals (CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets). With a strong presence in Europe, Middle East, and Africa (EMEA), the Americas, and the Asia-Pacific, Azelis has established itself as a key player in the specialty chemicals distribution sector. Founded in 1996 and headquartered in Antwerp, Belgium, the company employs over 3,000 professionals globally and has consistently delivered growth through strategic acquisitions and operational efficiency. Azelis has also been focusing on sustainability initiatives, aligning with global trends toward eco-friendly and responsible chemical distribution practices.
Based on current
Additional Sources for AZE Stock
AZE Stock Overview
Market Cap in USD | 4,172m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
AZE Stock Ratings
Growth Rating | -54.3 |
Fundamental | 60.2 |
Dividend Rating | 50.3 |
Rel. Strength | -38.2 |
Analysts | - |
Fair Price Momentum | 11.49 EUR |
Fair Price DCF | 54.78 EUR |
AZE Dividends
Dividend Yield 12m | 1.38% |
Yield on Cost 5y | 0.81% |
Annual Growth 5y | 54.20% |
Payout Consistency | 93.8% |
AZE Growth Ratios
Growth Correlation 3m | -91.8% |
Growth Correlation 12m | -5.2% |
Growth Correlation 5y | -69.2% |
CAGR 5y | -17.58% |
CAGR/Max DD 5y | -0.34 |
Sharpe Ratio 12m | -0.54 |
Alpha | -46.65 |
Beta | 0.614 |
Volatility | 37.08% |
Current Volume | 251.4k |
Average Volume 20d | 256.5k |
As of April 30, 2025, the stock is trading at EUR 13.33 with a total of 251,354 shares traded.
Over the past week, the price has changed by -12.30%, over one month by -17.87%, over three months by -31.82% and over the past year by -41.71%.
Yes, based on ValueRay Fundamental Analyses, Azelis (BR:AZE) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 60.16 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZE as of April 2025 is 11.49. This means that AZE is currently overvalued and has a potential downside of -13.8%.
Azelis has no consensus analysts rating.
According to ValueRays Forecast Model, AZE Azelis will be worth about 12.7 in April 2026. The stock is currently trading at 13.33. This means that the stock has a potential downside of -5.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 24.8 | 86.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 12.7 | -5% |